Biologics in children's autoimmune disorders: efficacy and safety.
about
Immunization of children with secondary immunodeficiencyNeutralizing anti-interleukin-1β antibodies modulate fetal blood-brain barrier function after ischemia.TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?A successful treatment of juvenile idiopathic arthritis with rituximab: A report of two cases.Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.Etanercept: efficacy and safety for approved indications.Making progress: preserving beta cells in type 1 diabetes.B cells participate in tolerance and autoimmunity through cytokine production.New age of biological therapies in paediatric rheumatology.Republished: new age of biological therapies in paediatric rheumatology.Juvenile idiopathic arthritis: management and therapeutic options.[Immunotherapy and infectious issues in multiple sclerosis. Self-injectable and oral drugs for immunotherapy].Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors.Biologic agents therapy for Saudi children with rheumatic diseases: indications and safety.Guidelines for medical treatment of acute Kawasaki disease: report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version).
P2860
Q26801474-7467D142-F471-442E-B087-76BE45F01C20Q27308341-9AC65F95-C8CC-4149-AE16-1DF3D59810DBQ36361083-63FA953A-0546-49CB-A649-2B73C6E69F97Q37296422-DA06609A-E86F-4A45-9DA5-3BC87252E5BEQ37561994-78E0B220-DC72-4E54-9AF9-6CA6B61549BEQ37954714-35F04048-571E-4FB5-B7AA-E38801A735D8Q37972677-0802B741-4D10-4560-8F33-26EEEB703468Q38163603-F12BE81B-6C83-4DA8-8AC8-FBA2CC5C02ECQ38195363-BDC9A528-8B81-49F3-B0C5-5A4719C34718Q38250593-FB51D5DD-B5CB-4CF4-BE28-2FE5B75E033FQ39243858-5D74CBC2-E08B-42AE-9398-81D6CAB2CE02Q41102110-5162649F-BB6D-4E93-88AA-D03DE3C8FEE1Q43762363-0E528E01-A8FE-40FE-A556-B41C98FF8BF0Q51146578-96773269-C01D-4750-874A-9CC33D918399Q54144614-A7B4ACFE-A579-46F8-9F6B-12E24D0DF9C2
P2860
Biologics in children's autoimmune disorders: efficacy and safety.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Biologics in children's autoimmune disorders: efficacy and safety.
@en
Biologics in children's autoimmune disorders: efficacy and safety.
@nl
type
label
Biologics in children's autoimmune disorders: efficacy and safety.
@en
Biologics in children's autoimmune disorders: efficacy and safety.
@nl
prefLabel
Biologics in children's autoimmune disorders: efficacy and safety.
@en
Biologics in children's autoimmune disorders: efficacy and safety.
@nl
P2093
P2860
P1476
Biologics in children's autoimmune disorders: efficacy and safety.
@en
P2093
Francesco Chiarelli
Luciana Breda
Marianna Del Torto
Sara De Sanctis
P2860
P2888
P304
P356
10.1007/S00431-010-1238-Z
P577
2010-06-17T00:00:00Z